Abstract:Hirudin is the most potent natural inhibitor of thrombin and a powerful anticoagulant. Large-scale production of recombinant hirudin is desirable for therapy. In this study, the gene encoding hirudin variant III was redesigned and synthesized by usingBacillus subtilispreferred codons, and the recombinant hirudin variant III (rHV3) was overexpressed inB. subtilisDB403 with strong anticoagulation activity for the first time. The hirudin activity from the supernatant of culture with optimized expression conditions could reach 210 ATU/ml. The protein in culture supernatant was precipitated by trichloroacetic acid, then desalted by ultrafiltration and purified by anion exchange chromatography. Strong anion Q F.F. performed better than weak anion DEAE F.F. The proper pH and conductivity was determined at pH 8 and 6 ms/cm, respectively. The maximum applied sample was 240 ATU/ml to medium of strong anion Q F.F. This optimized procedure was employed in strong anion exchange HiPrep 16/10Q with the 90% recovery rate and 70.2% purity. After gel filtration, the purity of rHV3 checked by HPLC could reach 95.1%, and the recovery rate was 93% for this step. The purified recombinant rHV3 showed a single band in SDS-PAGE. The rHV3 was stable at 100 °C and acidity condition, but was unstable under the condition of both heating and alkalinity. In conclusion, theses studies suggests thatB.subtilismight be useful for the production of biologically active medicine peptides in secretion facilitating purification procedures, and that this isolation method was suitable for scale-up purification process at a low cost.

[Fermentation, Purification and Identification of Recombinant RGD-Hirudin].

Expression, Purification, and Mass Spectrometric Analysis of 15N, 13C-Labeled RGD-hirudin, Expressed in Pichia Pastoris, for NMR Studies.

Prokaryotic Expression of SA-hirudin-RGD Fusion Proteinand Identification of Its Anticoagulant and Anti-platelet Aggregation Function

A Novel Hirudin Derivative Characterized with Anti-Platelet Aggregations and Thrombin Inhibition.

Expression, Purification and Characterization of the Recombinant Hirudin Variant Iii in the Bacillus Subtilis

Expression, purification, and characterization of recombinant lumbrokinase PI239 in Escherichia coli.

Expression, Purification and Characterization of Recombinant Human Coagulation Factor XIIIa in Pichia Pastoris

Construction and Expression of Chimeric Antithrombotics with Hirudin and RGD Sequence

Molecular cloning of hirudin derivative cDNA gene and expression in mammalian cell

Efficient targeted anticoagulant with active RGD motif.

The NMR Solution Structure of Recombinant RGD-hirudin

Overproduction of 15N-Labeled R-Rgd-hirudin in Pichia Pastoris for NMR Studies

1H NMR assignment and secondary structure of recombinant RGD-hirudin.

Studies on the Separation and Purification of Recombinant Hirudin Variant 3 from the Bacillus Subtilis

Structural basis of RGD-hirudin binding to thrombin: Tyr 3 and five C-terminal residues are crucial for inhibiting thrombin activity

Structure Study of Recombinant RGD-Hirudin by Vibrational and Circular Dichroism Spectroscopy

Simple and Efficient Methods for Isolation and Activity Measurement of the Recombinant Hirudin Variant 3 from Bacillus Subtilis

Construction of Fusion Recombinant Plasmid Coding for RGD Peptide and Urokinase B Chain, Its Expression in Escherichia coil and Preliminary Characterization of Its Biological Activity

[The Renaturation and Purification of RGD-staphylokinase by Gel Filtration].

[Construction of fusion recombinant plasmid coding for RGD peptide and urokinase B chain, its expression in Escherichia coli and preliminary characterization of its biological activity]

Gene Construction, Expression, Purification and Activity Analysis of Anti-platelet Aggregation Peptide RGD226